Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients

NCT01768559 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

894

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Lixisenatide (AVE0010)
DRUG: Insulin glulisine QD
DRUG: Insulin glulisine TID
DRUG: Insulin Glargine (Mandatory background drug)
DRUG: Metformin (Background drug)

Sponsor

Sanofi